Trump administration reschedules state-licensed medical marijuana to Schedule III
Updated
Updated · Scientific American · May 4
Trump administration reschedules state-licensed medical marijuana to Schedule III
9 articles · Updated · Scientific American · May 4
The change applies under the Controlled Substances Act and affects medical cannabis already permitted in 40 states and Washington, DC.
Researchers say moving marijuana from the same federal category as heroin should cut security and paperwork burdens, making clinical studies cheaper and easier.
Evidence remains strongest for chronic pain, chemotherapy nausea and multiple sclerosis symptoms, while many other claimed benefits still lack large-scale trial data.
With medical marijuana rescheduled, when will patients get FDA-approved treatments for common conditions like chronic pain?
A major study on marijuana's effects on older adults is due in 2027. What will it reveal about long-term safety?
As legal cannabis gets stronger and more accessible, are we prepared for the rising risks of addiction and impairment?